ANTICOAGULANTS
Clinical trials for ANTICOAGULANTS explained in plain language.
Never miss a new study
Get alerted when new ANTICOAGULANTS trials appear
Sign up with your email to follow new studies for ANTICOAGULANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests simpler blood thinner regimen after heart procedure
Disease control Recruiting nowThis study compares two blood thinner strategies after left atrial appendage closure (LAAC) in people with atrial fibrillation. Sixty participants will receive either aspirin alone or aspirin plus clopidogrel for three months. The goal is to see which approach better prevents sma…
Matched conditions: ANTICOAGULANTS
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New study tests safer stroke prevention for frail elderly with atrial fibrillation
Disease control Recruiting nowThis study compares two treatment strategies for elderly frail patients with atrial fibrillation (AF) who are at high risk for both stroke and bleeding. One group receives catheter ablation plus a device to close the left atrial appendage (LAAO), while the other receives ablation…
Matched conditions: ANTICOAGULANTS
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Should you pause your blood thinner before a heart procedure? a new study investigates.
Disease control Recruiting nowThis study looks at whether it is safer to stop or continue taking direct oral anticoagulants (blood thinners) during planned heart procedures like angiography or stent placement. About 1,270 adults with atrial fibrillation and coronary artery disease will be randomly assigned to…
Matched conditions: ANTICOAGULANTS
Phase: NA • Sponsor: Zuyderland Medisch Centrum • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could three doses a day prevent clots in pregnancy better than two?
Disease control Recruiting nowThis study tests whether taking the blood thinner Lovenox three times a day works better than the standard twice-a-day schedule for pregnant women at high risk of blood clots. Pregnancy increases clot risk fivefold, and many women on the standard schedule don't get enough protect…
Matched conditions: ANTICOAGULANTS
Phase: PHASE4 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC